A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, testicular cancer, testicular disorder, uterine disorder	Recruiting	Phase 1	2026-09-03		NCT06515613

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Context Therapeutics Inc.	3

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana-Farber Cancer Institute	Boston	United States	626
Duke Cancer Institute	Durham	United States	47
Fox Chase Cancer Center	Philadelphia	United States	259
Gabrail Cancer Center	Canton	United States	39
John Theurer Cancer Center	Hackensack	United States	20
Memorial Sloan Kettering Cancer Center	New York	United States	60
Precision NextGen Oncology & Research Center	Beverly Hills	United States	6
Providence Cancer Institute of Oregon	Portland	United States	2
SCRI at Denver Health	Denver	United States	1
SCRI at Mary Crowley	Dallas	United States	6
University College London Hospital	London	United Kingdom	32
University of Arkansas Winthrop P. Rockefeller Cancer Institute	Little Rock	United States	2
University of Nebraska Medical	Omaha	United States	1
Vanderbilt-Ingram Cancer Center	Nashville	United States	48
Women & Infants Hospital of Rhode Island	Providence	United States	9